GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Bcl2 | decreases expression | EXP | | 6480464 | CTD | Acetaminophen results in decreased expression of BCL2 mRNA; Acetaminophen results in decreased expression of BCL2 protein | PMID:22093918 PMID:26767949 | Bcl2 | increases expression | EXP | | 6480464 | CTD | Acetaminophen results in increased expression of BCL2 mRNA; Acetaminophen results in increased expression of BCL2 protein modified form | PMID:20166895 PMID:33387578 | Bcl2 | multiple interactions | EXP | | 6480464 | CTD | Acetaminophen inhibits the reaction [Vitamin K 3 results in decreased expression of BCL2 mRNA]; Acetaminophen inhibits the reaction [Vitamin K 3 results in decreased expression of BCL2 protein]; Hesperidin inhibits the reaction [Acetaminophen results in decreased expression of BCL2 mRNA]; Hesperidin inhibits the reaction [Acetaminophen results in decreased expression of BCL2 protein]; morin inhibits the reaction [Acetaminophen results in decreased expression of BCL2 protein]; pyrazolanthrone inhibits the reaction [Acetaminophen results in increased expression of BCL2 protein modified form]; Taurine inhibits the reaction [Acetaminophen results in increased expression of BCL2 protein modified form] | PMID:19265712 PMID:20166895 PMID:22093918 PMID:26767949 | Bcl2 | decreases expression | ISO | Bcl2 (Mus musculus) | 6480464 | CTD | Acetaminophen results in decreased expression of BCL2 protein | PMID:18467506 PMID:22939915 PMID:31697998 PMID:31967706 PMID:32040233 PMID:33571619 PMID:35166444 PMID:35179299 | Bcl2 | decreases expression | ISO | BCL2 (Homo sapiens) | 6480464 | CTD | Acetaminophen results in decreased expression of BCL2 mRNA | PMID:9444671 | Bcl2 | increases expression | ISO | Bcl2 (Mus musculus) | 6480464 | CTD | Acetaminophen results in increased expression of BCL2 mRNA; Acetaminophen results in increased expression of BCL2 protein | PMID:12540782 PMID:25319358 PMID:37046119 PMID:37179516 | Bcl2 | increases expression | ISO | BCL2 (Homo sapiens) | 6480464 | CTD | Acetaminophen results in increased expression of BCL2 mRNA | PMID:26690555 PMID:29067470 | Bcl2 | multiple interactions | ISO | Bcl2 (Mus musculus) | 6480464 | CTD | Acetaminophen promotes the reaction [saikosaponin D results in increased expression of BCL2 mRNA]; allicin inhibits the reaction [Acetaminophen results in decreased expression of BCL2 protein]; amlexanox inhibits the reaction [Acetaminophen results in decreased expression of BCL2 protein]; CHAC2 protein promotes the reaction [naringin inhibits the reaction [Acetaminophen results in decreased expression of BCL2 protein]]; dioscin inhibits the reaction [Acetaminophen results in decreased expression of BCL2 protein]; Irbesartan inhibits the reaction [Acetaminophen results in decreased expression of BCL2 protein]; KITL protein inhibits the reaction [Acetaminophen results in decreased expression of BCL2 protein]; naringin inhibits the reaction [Acetaminophen results in decreased expression of BCL2 protein]; NFE2L2 protein promotes the reaction [naringin inhibits the reaction [Acetaminophen results in decreased expression of BCL2 protein]]; O(2)-vinyl-1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate inhibits the reaction [Acetaminophen results in increased expression of BCL2 mRNA]; P2RX1 protein affects the reaction [Acetaminophen results in increased expression of BCL2 protein]; schizandrol B promotes the reaction [Acetaminophen results in increased expression of BCL2 protein] | PMID:12540782 PMID:18467506 PMID:22939915 PMID:25265579 PMID:25319358 PMID:31697998 PMID:31967706 PMID:32040233 PMID:35166444 PMID:35179299 PMID:37046119 | |
Go Back to source page | Continue to Ontology report |